Elevance Health (MEX:ELV) LT-Debt-to-Total-Asset: 0.25 (As of Mar. 2026)


MEX:ELV Elevance Health Inc MEX:ELV
71 GF Score
Price MXN7,144.06
GF Value MXN8,687.10
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Elevance Health LT-Debt-to-Total-Asset?

Elevance Health MEX:ELV 71 LT-Debt-to-Total-Asset is 0.25 as of Mar. 2026. GuruFocus rates MEX:ELV with a GF Score™ of 71/100 and a GF Value™ of MXN8,687.10 (Modestly Undervalued). The stock has 8 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Elevance Health's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.25.

Elevance Health's long-term debt to total assets ratio increased from Mar. 2025 (0.24) to Mar. 2026 (0.25). It may suggest that Elevance Health is progressively becoming more dependent on debt to grow their business.

Elevance Health  (MEX:ELV) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Elevance Health LT-Debt-to-Total-Asset Related Terms

Elevance Health LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Elevance Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health LT-Debt-to-Total-Asset Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.22 0.21 0.25 0.25

Elevance Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.23 0.25 0.25 0.25
MEX:ELV
71GF Score
Elevance Health Inc MEX:ELV
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health LT-Debt-to-Total-Asset Calculation

Elevance Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=554521.543/2187584.517
=0.25

Elevance Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=554830.114/2269000.545
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.25 mean?
Elevance Health (MEX:ELV) has a LT-Debt-to-Total-Asset of 0.25 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Elevance Health and its competitors.
Is Elevance Health's LT-Debt-to-Total-Asset too high?
Elevance Health's current LT-Debt-to-Total-Asset is 0.25. Overall, Elevance Health has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's LT-Debt-to-Total-Asset compare to CI and HUM?
Elevance Health's LT-Debt-to-Total-Asset of 0.25 can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Healthcare Plans company?
A good LT-Debt-to-Total-Asset depends on the Healthcare Plans industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Elevance Health and its competitors. Elevance Health's current LT-Debt-to-Total-Asset is 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,687.10, compared to a current price of MXN7,144.06 — trading 17.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.25. Elevance Health's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current LT-Debt-to-Total-Asset is 0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (MEX:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of MXN7,144.06 is trading 17.8% below its estimated GF Value™ of MXN8,687.10. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for MEX:ELV:

  • LT-Debt-to-Total-Asset: 0.25
  • GF Value™: MXN8,687.10 vs. price of MXN7,144.06 (17.8% below fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
71GF Score

Get the complete analysis for MEX:ELV

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN7,144.06
Price
MXN8,687.10
GF Value